GUNS N' ROSES and METALLICA have made Pollstar's top 20 worldwide tours of 2017. GNR's "Not In This Lifetime" trek finished at No. 2 with 2.68 million tickets sold, behind U2's "Joshua Tree" tour, which topped the list with 2.71 million tickets sold. METALLICA's "WorldWired" trek was the fifth-highest grossing tour, with 1.5 million tickets sold. GUNS N' ROSES' most recent North American run of arena dates started in October and included three nights at Madison Square Garden Arena, two at Toronto's Air Canada Centre and two shows at the Forum in Inglewood, California. For all of the Americas in 2017, which included a leg in North American stadiums earlier this year as well as a few big outdoor plays in South America with THE WHO in support, GN'R sold 993,765 tickets and grossed a total of more than $109 million, as submitted to Pollstar. GUNS N' ROSES will return next June for a seven-week European jaunt, but the band's plans until then, and beyond that, remain unknown for now. The three original members have not given a single interview together. The reunited trio, along with four backing musicians from latter lineups, have been on the road almost continuously since the tour was launched with a surprise show at the Troubadour nightclub in Los Angeles on April 1, 2016. Although some fans have grumbled that two members of the original lineup — guitarist Izzy Stradlin and drummer Steven Adler, the latter of whom did appear at a handful of stops on the tour — remain on the sidelines, the trek has been wildly successful, reportedly grossing more than $400 million since its launch a year and a half ago. The European leg of METALLICA's "WorldWired" tour kicked off in Copenhagen, Denmark on September 2 and ran through November 3. After a break, the trek will pick up again on February 1, 2018 in Lisbon, Portugal, and continue through May, finishing up in Helsinki, Finland. The Rock And Roll Hall Of Fame band is touring in support of its tenth studio album, "Hardwired... To Self-Destruct", which came out in November 2016.
Continue reading...
Continue reading...
